The Impact of Intraoperative Ketamine on Postoperative Depression and Anxiety in Patients with Preexisting Depression and Anxiety Undergoing Total Hip Arthroplasty

Background: Depression and anxiety are common among patients having total hip arthroplasty (THA) and are linked to worse postoperative results. Ketamine is a dissociative anesthetic with antidepressant effects and has gained popularity as a perioperative treatment for mental conditions like major depressive disorder (MDD) and generalized anxiety disorder (GAD). Objective: To evaluate whether intraoperative ketamine administration improves short-term postoperative mental health outcomes in THA patients with preexisting MDD and/or GAD. Methodology: A retrospective cohort analysis was conducted utilizing TriNetX’s Global Collaborative Network, with 152 healthcare institutions analyzed. We included adult patients (≥18 years) receiving THA with diagnoses of generalized anxiety disorder, major depressive disorder, or depressive episode. Two cohorts were formed using 1:1 propensity score matching to compare age, gender, and other characteristics. The cohorts included patients who received intraoperative ketamine (n = 21,394) as well as those who did not. Depressive and anxiety episodes, as well as psychiatric drug use, were monitored and studied throughout a 90-day postoperative period. Results: Compared to the controls, the ketamine group had a significantly higher risk of depressive episodes (24.9% vs. 20.2%; risk ratio [RR] 1.24; odds ratio [OR] 1.31; hazard ratio [HR] 1.28; p<0.0001), anxiety disorders (22.7% vs. 17.6%; RR 1.29; OR 1.37; HR 1.34; p<0.0001), and psychiatric medication use (38.6% vs. 35.8%; RR 1.08; OR 1.13; HR 1.09; p<0.0001). Conclusion: Our study showed that intraoperative ketamine was associated with a higher short-term risk and earlier onset of postoperative psychiatric symptoms in patients with a history of depression or anxiety undergoing THA. These findings challenge the previous literature on ketamine’s perioperative psychiatric benefits and highlight the need for further prospective studies.

Authors

Publication Details

Journal
medtigo Journal of Medicine
Published
2025-09-02
DOI
https://doi.org/10.63096/medtigo3067127
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Impact of Intraoperative Ketamine on Postoperative Depression and Anxiety in Patients with Preexisting Depression and Anxiety Undergoing Total Hip Arthroplasty

Miriam B Michael, Lucia Light, Michael L. Scott, Syed A Gillani et al.
medtigo Journal of Medicine
Treatment of Major Depression
article

The Impact of Intraoperative Ketamine on Postoperative Depression and Anxiety in Patients with Preexisting Depression and Anxiety Undergoing Total Hip Arthroplasty

Miriam B Michael, Lucia Light, Michael L. Scott, Syed A Gillani, Rawan Elkomi, Tegshjargal Baasansukh, Chukwudalu Ononenyi, Ayomide Ogunsakin
article en

Abstract

Background: Depression and anxiety are common among patients having total hip arthroplasty (THA) and are linked to worse postoperative results. Ketamine is a dissociative anesthetic with antidepressant effects and has gained popularity as a perioperative treatment for mental conditions like major depressive disorder (MDD) and generalized anxiety disorder (GAD). Objective: To evaluate whether intraoperative ketamine administration improves short-term postoperative mental health outcomes in THA patients with preexisting MDD and/or GAD. Methodology: A retrospective cohort analysis was conducted utilizing TriNetX’s Global Collaborative Network, with 152 healthcare institutions analyzed. We included adult patients (≥18 years) receiving THA with diagnoses of generalized anxiety disorder, major depressive disorder, or depressive episode. Two cohorts were formed using 1:1 propensity score matching to compare age, gender, and other characteristics. The cohorts included patients who received intraoperative ketamine (n = 21,394) as well as those who did not. Depressive and anxiety episodes, as well as psychiatric drug use, were monitored and studied throughout a 90-day postoperative period. Results: Compared to the controls, the ketamine group had a significantly higher risk of depressive episodes (24.9% vs. 20.2%; risk ratio [RR] 1.24; odds ratio [OR] 1.31; hazard ratio [HR] 1.28; p<0.0001), anxiety disorders (22.7% vs. 17.6%; RR 1.29; OR 1.37; HR 1.34; p<0.0001), and psychiatric medication use (38.6% vs. 35.8%; RR 1.08; OR 1.13; HR 1.09; p<0.0001). Conclusion: Our study showed that intraoperative ketamine was associated with a higher short-term risk and earlier onset of postoperative psychiatric symptoms in patients with a history of depression or anxiety undergoing THA. These findings challenge the previous literature on ketamine’s perioperative psychiatric benefits and highlight the need for further prospective studies.

medtigo Journal of MedicineVol. 1(1)
Openalex Percentile: Top 74%
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.